Neurovance Obtains $314,601 New Funding Round

  • Feed Type
  • Date
    5/31/2012
  • Company Name
    Neurovance
  • Mailing Address
    43 Thorndike Street Cambridge, MA 02141
  • Company Description
    Neurovance is a stealth pharmaceutical company developing pharmaceutical preparations for the treatment of disorder of the central nervous system.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $314,601
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.